HRP20080075T3 - Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists - Google Patents

Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists

Info

Publication number: HRP20080075T3
Authority: HR; Croatia
Prior art keywords: phenyl; alkyl; hydrogen; phenylalkyl; group
Prior art date: 2004-12-30

Application number

HR20080075T

Other languages

English (en)

Croatian (hr)

Inventor

Gmeiner Peter

H�bner Harald

Schlotter Karin

Original Assignee

Schwarz Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-30

Filing date

2008-02-19

Publication date

2008-03-31

2008-02-19 Application filed by Schwarz Pharma Ag filed Critical Schwarz Pharma Ag

2008-03-31 Publication of HRP20080075T3 publication Critical patent/HRP20080075T3/xx

Links

229910052760 oxygen Inorganic materials 0.000 title abstract 3
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 2
239000005557 antagonist Substances 0.000 title 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title 1
229960003638 dopamine Drugs 0.000 title 1
FKRLWISOOAJICU-UHFFFAOYSA-N n-phenyldiazepane-1-carboxamide Chemical class C1CCCCNN1C(=O)NC1=CC=CC=C1 FKRLWISOOAJICU-UHFFFAOYSA-N 0.000 title 1
YEQDVKYOHVLZPU-UHFFFAOYSA-N n-phenylpiperazine-1-carboxamide Chemical class C1CNCCN1C(=O)NC1=CC=CC=C1 YEQDVKYOHVLZPU-UHFFFAOYSA-N 0.000 title 1
239000001301 oxygen Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 6
229910052739 hydrogen Inorganic materials 0.000 abstract 6
239000001257 hydrogen Substances 0.000 abstract 6
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
125000003884 phenylalkyl group Chemical group 0.000 abstract 5
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
-1 phenylalkylcarbonyl Chemical group 0.000 abstract 4
125000003545 alkoxy group Chemical group 0.000 abstract 3
125000004448 alkyl carbonyl group Chemical group 0.000 abstract 3
125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 3
229910052736 halogen Inorganic materials 0.000 abstract 3
150000002367 halogens Chemical class 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 2
125000004471 alkyl aminosulfonyl group Chemical group 0.000 abstract 2
125000004656 alkyl sulfonylamino group Chemical group 0.000 abstract 2
125000004414 alkyl thio group Chemical group 0.000 abstract 2
125000000304 alkynyl group Chemical group 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 2
125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 abstract 2
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
150000001412 amines Chemical class 0.000 abstract 1
125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 abstract 1
125000004432 carbon atom Chemical group C* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
239000012458 free base Substances 0.000 abstract 1
125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
125000004043 oxo group Chemical group O=* 0.000 abstract 1
125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
229930195734 saturated hydrocarbon Natural products 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
229930195735 unsaturated hydrocarbon Natural products 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Ophthalmology & Optometry (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Polyesters Or Polycarbonates (AREA)
External Artificial Organs (AREA)

HR20080075T 2004-12-30 2008-02-19 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists HRP20080075T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102004063797A DE102004063797A1 (de)	2004-12-30	2004-12-30	Sauerstoffhaltige annelierte Phenylpiperazin- und Phenyldiazepancarboxamide
PCT/EP2005/014047 WO2006072430A1 (de)	2004-12-30	2005-12-27	Sauerstoffhaltige annelierte phenylpiperazin- und phenyldiazepancarboxamide als dopamin d3 antagonisten

Publications (1)

Publication Number	Publication Date
HRP20080075T3 true HRP20080075T3 (en)	2008-03-31

Family

ID=36102609

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20080075T HRP20080075T3 (en)	2004-12-30	2008-02-19	Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists

Country Status (22)

Country	Link
US (1)	US20080194539A1 (xx)
EP (1)	EP1761524B1 (xx)
JP (1)	JP2008526700A (xx)
KR (1)	KR20070102673A (xx)
CN (1)	CN101027294A (xx)
AU (1)	AU2005324107A1 (xx)
BR (1)	BRPI0519485A2 (xx)
CA (1)	CA2576332A1 (xx)
DE (2)	DE102004063797A1 (xx)
DK (1)	DK1761524T3 (xx)
EA (1)	EA200701366A1 (xx)
ES (1)	ES2297767T3 (xx)
HK (1)	HK1100845A1 (xx)
HR (1)	HRP20080075T3 (xx)
IL (1)	IL180763A0 (xx)
MX (1)	MX2007006369A (xx)
NO (1)	NO20072587L (xx)
PL (1)	PL1761524T3 (xx)
PT (1)	PT1761524E (xx)
SI (1)	SI1761524T1 (xx)
WO (1)	WO2006072430A1 (xx)
ZA (1)	ZA200701972B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9227944B2 (en)	2008-10-10	2016-01-05	Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China	Dopamine D3 receptor ligands and preparation and medical uses of the same
JP5701213B2 (ja) *	2008-10-10	2015-04-15	インスティチュートオブファーマコロジーアンドトキシコロジーアカデミーオブミリタリーメディカルサイエンシズピー．エル．エー．チャイナ	新規なドーパミンｄ３受容体リガンド、その調製及び使用
UA107657C2 (xx) *	2009-03-10	2015-02-10	Такеда Фармасьютікал Компані Лімітед	Похідні бензофурану
CN103282369A (zh) *	2011-04-08	2013-09-04	劳乐斯实验室私营有限公司	抗逆转录病毒化合物与抗氧化酸的固体形式、其制备方法以及其药物组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL90279A (en) *	1988-05-24	1995-03-30	American Home Prod	History of piperazinyl carboxamide, their preparation and the pharmaceutical preparations containing them
IL92544A0 (en) *	1988-12-08	1990-08-31	Duphar Int Res	Piperazine derivatives,their preparation and pharmaceutical compositions containing them
DE4127849A1 (de) *	1991-08-22	1993-02-25	Merck Patent Gmbh	Benzodioxanderivate
DE4333254A1 (de) *	1993-09-30	1995-04-06	Merck Patent Gmbh	Piperidine und Piperazine
DE69819173T2 (de) *	1997-07-25	2004-04-15	H. Lundbeck A/S	Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
FR2781671A1 (fr) *	1998-07-28	2000-02-04	Synthelabo	Compositions pharmaceutiques contenant un inhibiteur de la recapture de la serotonine et leur application en therapeutique
AR022303A1 (es) *	1999-01-22	2002-09-04	Lundbeck & Co As H	Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion
GB9905010D0 (en) *	1999-03-04	1999-04-28	Merck Sharp & Dohme	Therapeutic agents
ES2188344B1 (es) *	2000-11-29	2004-09-16	Laboratorios Vita, S.A.	Compuestos derivados de benzotiofeno, su procedimiento de obtencion y utilizacion de los mismos.
HUP0103987A3 (en) *	2001-09-28	2004-11-29	Richter Gedeon Vegyeszet	Phenylpiperazinylalkyl carboxylic acid amid derivatives, process for their preparation, pharmaceutical compositions containing them and their intermediates
WO2004004729A1 (de) *	2002-07-04	2004-01-15	Schwarz Pharma Ag	Heteroarencarboxamide zur verwendung als dopamin-d3 liganden zur behandlung von zns-erkrankungen
AU2003267201B2 (en) *	2002-09-14	2009-04-23	The Gov't Of The U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services	Structurally rigid dopamine D3 receptor selective ligands and process for making them
DE10259244A1 (de) *	2002-12-17	2004-07-01	Merck Patent Gmbh	N-(Indolethyl-)cycloamin-Verbindungen
US20040192730A1 (en) *	2003-03-13	2004-09-30	Dynogen Pharmaceuticals, Inc.	Methods of using compounds with combined 5-HT1A and SSRI activities as-needed to treat sexual dysfunction

2004
- 2004-12-30 DE DE102004063797A patent/DE102004063797A1/de not_active Ceased
2005
- 2005-12-27 US US11/794,386 patent/US20080194539A1/en not_active Abandoned
- 2005-12-27 EP EP05823871A patent/EP1761524B1/de active Active
- 2005-12-27 WO PCT/EP2005/014047 patent/WO2006072430A1/de active IP Right Grant
- 2005-12-27 DE DE502005002058T patent/DE502005002058D1/de not_active Expired - Fee Related
- 2005-12-27 PT PT05823871T patent/PT1761524E/pt unknown
- 2005-12-27 ES ES05823871T patent/ES2297767T3/es active Active
- 2005-12-27 KR KR1020077014615A patent/KR20070102673A/ko not_active Application Discontinuation
- 2005-12-27 BR BRPI0519485-7A patent/BRPI0519485A2/pt not_active Application Discontinuation
- 2005-12-27 CA CA002576332A patent/CA2576332A1/en not_active Abandoned
- 2005-12-27 SI SI200530145T patent/SI1761524T1/sl unknown
- 2005-12-27 JP JP2007548748A patent/JP2008526700A/ja active Pending
- 2005-12-27 MX MX2007006369A patent/MX2007006369A/es not_active Application Discontinuation
- 2005-12-27 PL PL05823871T patent/PL1761524T3/pl unknown
- 2005-12-27 DK DK05823871T patent/DK1761524T3/da active
- 2005-12-27 CN CNA2005800324230A patent/CN101027294A/zh active Pending
- 2005-12-27 AU AU2005324107A patent/AU2005324107A1/en not_active Abandoned
- 2005-12-27 EA EA200701366A patent/EA200701366A1/ru unknown
2007
- 2007-01-17 IL IL180763A patent/IL180763A0/en unknown
- 2007-01-18 ZA ZA200701972A patent/ZA200701972B/en unknown
- 2007-05-21 NO NO20072587A patent/NO20072587L/no not_active Application Discontinuation
- 2007-06-05 HK HK07105930A patent/HK1100845A1/xx not_active IP Right Cessation
2008
- 2008-02-19 HR HR20080075T patent/HRP20080075T3/xx unknown

Also Published As

Publication number	Publication date
DK1761524T3 (da)	2008-04-07
DE502005002058D1 (de)	2008-01-03
AU2005324107A1 (en)	2006-07-13
MX2007006369A (es)	2007-07-11
JP2008526700A (ja)	2008-07-24
CA2576332A1 (en)	2006-07-13
KR20070102673A (ko)	2007-10-19
ES2297767T3 (es)	2008-05-01
PL1761524T3 (pl)	2008-04-30
PT1761524E (pt)	2008-02-21
SI1761524T1 (sl)	2008-04-30
EP1761524A1 (de)	2007-03-14
HK1100845A1 (en)	2007-09-28
BRPI0519485A2 (pt)	2009-02-03
WO2006072430A1 (de)	2006-07-13
EA200701366A1 (ru)	2008-02-28
ZA200701972B (en)	2008-04-30
CN101027294A (zh)	2007-08-29
NO20072587L (no)	2007-05-21
EP1761524B1 (de)	2007-11-21
US20080194539A1 (en)	2008-08-14
DE102004063797A1 (de)	2006-07-13
AU2005324107A2 (en)	2006-07-13
IL180763A0 (en)	2007-06-03

Publication	Publication Date	Title
HRP20070510T3 (en)	2007-12-31	Benzimidazole derivative and its use as a ii receptor antagonist
PE20071286A1 (es)	2008-03-02	Composicion para inducir tolerancia viral en plantas
EA200900606A1 (ru)	2009-08-28	Новые сульфониламидные производные в качестве антагонистов брадикининовых рецепторов
MXPA05004188A (es)	2005-10-05	Antagonistas de cgrp elegidos, procedimiento para su preparacion, asi como su empleo como medicamentos.
WO2003106428A8 (fr)	2004-05-06	Derives d'arylsulfonamides et leur utilisation en tant que antagonistes au recepteur b1 de la bradykinine
DK1755606T3 (da)	2008-03-03	Quinazolinonderivater, der er anvendelige som vanilloid-antagonister
RS51007B (sr)	2010-10-31	Supstituisani piridinil i pirimidinil derivati kao modulatori metabolizma i lečenje poremećaja proisteklih iz toga
RS50552B (sr)	2010-05-07	Derivati pirolopiridina i njihova upotreba kao antagonista crth2
BRPI0508966A (pt)	2007-08-21	composto, composição farmacêutica, e, uso de um composto
RS20050311A (xx)	2007-08-03	Odabrani cgrp antagonisti, postupci za njihovo dobijanje i njihovo korišćenje u vidu farmaceutskih kompozicija
MY134701A (en)	2007-12-31	Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
ZA201102735B (en)	2012-12-27	Antagonists of the vanilloid receptor subtype 1(vr1) and uses thereof
HRP20050390A2 (en)	2006-12-31	Substituted benzoxazinones and uses thereof
HRP20050362B1 (hr)	2014-01-31	3-fenil supstituirani piridoindolon, njegovo dobivanje i njegova terapijska upotreba
RS52679B (en)	2013-06-28	RENIN INHIBITORS
MX344529B (es)	2016-12-19	Derivados antibioticos de 2 - oxo -oxazolidin - 3, 5 -diilo.
AR060810A1 (es)	2008-07-16	Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn
AR060812A1 (es)	2008-07-16	Moduladores de receptores metabotropicos de glutamato mglur5, composiciones farmaceuticas que los contienen y usos en procesos patofisiologicos y trastornos que afectan el scn
TNSN08522A1 (en)	2010-04-14	Cinnamoyl-piperazine derivatives and their use as par - 1 antagonists
HRP20080075T3 (en)	2008-03-31	Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists
TW200604185A (en)	2006-02-01	Chemical compounds
HRP20080363T3 (en)	2008-09-30	Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists
DK1899331T3 (da)	2010-03-08	Homomorpholinoxazolidnoner som antibakterielle midler
PE20020052A1 (es)	2002-02-02	Derivados de sulfonamidas util para potenciar la funcion del receptor de glutamato
AR029729A1 (es)	2003-07-10	Derivados de polifluoroalquiltriazol, su preparacion y su utilizacion en terapeutica